D Downrigt Member Member May 8, 2018 #1 Is LGD the only SARM to be tested on humans? Anyone have any idea what will be the next SARM to be tested on humans?
Is LGD the only SARM to be tested on humans? Anyone have any idea what will be the next SARM to be tested on humans?
MasonicBodybuilder Moderator VIP Moderator May 8, 2018 #2 There wont be any testing of SARMs on humans.
DylanGemelli Founding Member Super Moderator May 8, 2018 #4 no clue if they will have human testing.. go to pubmed, theres plenty of studies there man
D Downrigt Member Member May 8, 2018 #5 DylanGemelli said: no clue if they will have human testing.. go to pubmed, theres plenty of studies there man Click to expand... Thanks!!!!
DylanGemelli said: no clue if they will have human testing.. go to pubmed, theres plenty of studies there man Click to expand... Thanks!!!!
DylanGemelli Founding Member Super Moderator May 8, 2018 #6 Downrigt said: Thanks!!!! Click to expand... Anytime bro Sent from my iPhone using Tapatalk Pro
N norep90 New member Member May 10, 2018 #7 Study of GTx-024 on Muscle Wasting (Cachexia) Cancer https://clinicaltrials.gov/ct2/show/NCT00467844 https://www.ncbi.nlm.nih.gov/pubmed/23499390?dopt=Abstract A Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Hormone Receptor Positive Breast Cancer https://clinicaltrials.gov/ct2/show/NCT03088527 GTx-024 as a Treatment for Stress Urinary Incontinence in Women https://clinicaltrials.gov/ct2/show/NCT02658448 Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) https://clinicaltrials.gov/ct2/show/NCT01355484 Add-on Study for Protocol G200802 (NCT02463032): Effect of GTx-024 on Maximal Neuromuscular Function and Lean Body Mass https://clinicaltrials.gov/ct2/show/NCT02746328 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of GSK2881078 in Single and Repeat Doses https://clinicaltrials.gov/ct2/show/NCT02045940 Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males https://clinicaltrials.gov/ct2/show/NCT00540553 Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD) https://clinicaltrials.gov/ct2/show/NCT03359473 And many more.
Study of GTx-024 on Muscle Wasting (Cachexia) Cancer https://clinicaltrials.gov/ct2/show/NCT00467844 https://www.ncbi.nlm.nih.gov/pubmed/23499390?dopt=Abstract A Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Hormone Receptor Positive Breast Cancer https://clinicaltrials.gov/ct2/show/NCT03088527 GTx-024 as a Treatment for Stress Urinary Incontinence in Women https://clinicaltrials.gov/ct2/show/NCT02658448 Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) https://clinicaltrials.gov/ct2/show/NCT01355484 Add-on Study for Protocol G200802 (NCT02463032): Effect of GTx-024 on Maximal Neuromuscular Function and Lean Body Mass https://clinicaltrials.gov/ct2/show/NCT02746328 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of GSK2881078 in Single and Repeat Doses https://clinicaltrials.gov/ct2/show/NCT02045940 Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males https://clinicaltrials.gov/ct2/show/NCT00540553 Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD) https://clinicaltrials.gov/ct2/show/NCT03359473 And many more.